NCT04976855View on ClinicalTrials.gov

Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

July 5, 2023

Study Completion Date

July 5, 2023

Conditions
Healthy VolunteerOpioid-use Disorder
Interventions
DRUG

INDV-2000

Capsule for oral administration

DRUG

Placebo

Capsule for oral administration

DRUG

SUBOXONE® sublingual film

Administered either under the tongue (sublingual) or between the gum and cheek (buccal)

Trial Locations (3)

21224

Johns Hopkins University School of Medicine BPRU, Baltimore

75115

InSite Clinical Research, DeSoto

78217

Worldwide Clinical Trials, San Antonio

Sponsors

Lead Sponsor

Indivior Inc.
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Indivior Inc.

INDUSTRY

NCT04976855 - Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder | Biotech Hunter | Biotech Hunter